Notice of Pre-Consultation - Draft Tamper-Resistant Properties of Drugs Regulations
Notice to the reader:
The online consultation is now closed. Comments and suggestions received during the public consultation period are being considered. Thank you for your input.
As part of the government’s comprehensive approach to addressing prescription drug abuse, Health Canada has drafted a new set of regulations, namely the Tamper-Resistant Properties of Drugs Regulations under the Controlled Drugs and Substances Act. The draft regulations would address the risks to public health and safety associated with tampering with prescription drugs for recreational use. The draft regulations would require therapeutic products containing controlled release oxycodone to have tamper-resistant properties approved by Health Canada in accordance with the Food and Drug Regulations before they could be sold in Canada.
Health Canada published the Notice of Pre-Consultation – Draft Tamper-Resistant Properties of Drugs Regulations in the Canada Gazette, Part I on June 27, 2015 seeking input from stakeholders and the general public with respect to the proposed regulations, with a 45 day comment period.
How to get Involved
The consultation is open for comment from June 27, 2015 until August 11, 2015.
A copy of the proposed regulations and a supporting stakeholder questionnaire can be requested by email at email@example.com or by mail at 150 Tunney’s Pasture Driveway, Main Statistics Canada Building, Address Locator: 0302A, Ottawa, Ontario K1A 0K9.
Comments in response to the Notice can be submitted electronically via email or by mail to the above coordinates.
Report a problem or mistake on this page
- Date modified: